Marker Therapeutics
MRKR | NASDAQ
$0.83
-$0.04 (-4.60%)
At close: Nov 16, 2026, 4:00 PM ET
$0.82
-$0.01 (-1.07%)
After-hours:
Nov 16, 2026, 4:43 PM ET
-4.60%
(1D)No price chart data available for 1D timeframe.
Rating
23
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #966/1021 (Top 95%)
Key Statistics
Market Data
Market Cap $16.03M
1D Range
0.82 0.91
52W Range
0.82 2.19
Valuation (TTM)
PE -1.73
PB 1.32
EV/EBITDA -0.54
Valuation (NTM)
Forward PE N/A
Forward PEG -0.04
Price Target $0.00
Cash Flow
FCF Yield -60.9%
SBC Adj. FCF Yield -63.0%
SBC Impact -3.5%
Margins
Gross Margin -320.8%
Operating Margin -869.0%
FCF Margin -791.3%
Growth (CAGR)
Revenue 3Y | 5Y -31.0% |
-5.5%
Dil EPS 3Y | 5Y 34.3% |
48.0%
FCF 3Y | 5Y 5.4% |
32.1%
Returns
ROA -59.7%
ROE -57.0%
ROIC -87.9%
Financial Health
Net Cash
$11.33M
Current Ratio 6.03
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Jul 16, 2002
Website www.markertherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MRKR